Login Logout My Account

The Cheap Investor
Making Wise Investments Since 2010
The Cheap InvestorThe Cheap Investor
  • Home
  • Track Record
  • Contact
  • Subscribe
  • Articles
  • Home
  • Track Record
  • Contact
  • Subscribe
  • Articles

Articles

Aug302016

Chart of Day: Bovie Medical (BVX) Soars 159%

Daily Chart, EmailBy Bill MathewsAugust 30, 2016Leave a comment

The summer was one of the most profitable on record for us, too.  In fact, since May, here are just some of the wins collected by subscribers: Bovie Medical Corporation (BVX) up 159% Rigel Pharmaceuticals (RIGL) up 29% Goldfield Corporation (GV) up 106% MeetMe Inc. (MEET) up 135% Adverum Biotechnologies (ADVM) up 37% Groupon Inc.…

Details
Aug292016

EpiPen Debate: Why Drug Delivery System is So Expensive

Email, Hot TrendsBy Bill MathewsAugust 29, 2016Leave a comment

The pharmaceuticals industry is no stranger to controversy. Plagued with runaway drug prices that have drawn the ire of Americans, the industry has come under fire, most recently from Democratic presidential nominee Hillary Clinton. But it’s not just the high cost of drugs that’s upset her. It’s also the high cost of drug delivery systems.…

Details

Two Rules For New Gold Buyers

Email, New RageBy Bill MathewsAugust 28, 20161 Comment

$106,848 That’s how much it cost to run a full page ad in Section C of the New York Times. A big layout for most businesses. It’s easily justified cost for a wide-release movie. It can also be absorbed in the “branding” efforts of a big companies like Samsung who spend as much as $15…

Details
Aug252016

The Dirty (And Profitable) Secret About This Year’s Worst-Performing ETF

Email, New RageBy Bill MathewsAugust 25, 2016Leave a comment

Biotech is back…it seems. The NASDAQ Biotechnology Index is up 19% in the last month. However, I’ve got to warn you, a year and a half into the correction, I’m still not buying it at all. Here’s why. The Hidden Biotech Bust In March 2015 your editor warned: The risk/reward of biotech stocks as a…

Details
Aug232016

Chart of Day: The Biotech M&A Boom Continues

Daily Chart, EmailBy Bill MathewsAugust 23, 2016Leave a comment

In early April 2016, we noted, “Biotech may have had a rough start to the year, lagging many other sectors. But don’t count it out just yet.  In fact, buy all you can.  The same strong catalysts and fundamentals are still firmly in place. Even though the first quarter of 2016 showed slower M&A activity,…

Details
Aug232016

How I’m Preparing For the Next Market Drop

Email, New RageBy Bill MathewsAugust 23, 2016Leave a comment

“This is a vote that changes everything.” That’s the quote we took the Financial Times following the Brexit referendum. It has now been two months since the Brexit was approved by voters and, in a way, everything has changed.  Running With The Herd We felt a little bit like we were losing our minds watching…

Details
Aug232016

Note to Federal Reserve: It’s too soon to Raise Rates

Email, Market InsiderBy Bill MathewsAugust 23, 2016Leave a comment

The last time the Federal Reserve raised the interest rate was in December 2015. At the time, the central bank was confident the economy was strong enough to handle higher borrowing costs.  But as they learned soon after, they were wrong.  Their optimism was premature.  The economy wasn’t ready.  World markets plunged thousands of points,…

Details
Aug222016

Hillary Clinton 2016: Where she stands on taxes

Email, Money MasteryBy Bill MathewsAugust 22, 2016Leave a comment

It’s looking like a nose-to-nose fight to the finish. At the moment, 41% of Americans are in favor of Hillary Clinton.  Another 37% backs Donald Trump.  About 10% are in favor of Libertarian candidate Gary Johnson, and another 4% in favor of Green Party candidate Jill Stein. But it’s the main contenders that are generating…

Details
Aug192016

Why Are Billionaires Piling Into This 4000% Growth Industry?

Email, Market InsiderBy Bill MathewsAugust 19, 2016Leave a comment

It’s my favorite time of year. Yes, I live in Scottsdale, Arizona. It’s August. The heat is unbearable. The town grounds to a halt when it passed 110 degrees. The only way to get things done outside is when it’s in the low 80s well before 6:00 AM. But that’s not why you’ll see me…

Details
Aug182016

One Sure-Fire Way To Win in an Upside Financial World

Email, Hot TrendsBy Bill MathewsAugust 18, 2016Leave a comment

The financial world is completely upside down. Government bonds have negative yields. Banks are only avoiding charging negative interest rates (which would be charging you money for holding your money) by adding and hiking fees. The average mortgage rate is 2.67%. That’s a full 1% below the rate of inflation if you calculate inflation using…

Details
Aug162016

Chart of Day: Dow 20,000?

Daily Chart, EmailBy Bill MathewsAugust 16, 2016Leave a comment

Dow Jones 36,000 may remain a pipe dream.  But analyst expectations for 20,000 could soon be reality.  In fact, as of last week, the consensus one-year estimate on Wall Street is now 20,003.93, up from an earlier projection of 19,914.  And it’s not as farfetched as you’d think especially in such a low interest rate…

Details
Aug162016

Donald Trump 2016: Where he stands on Taxes

Email, Hot TrendsBy Bill MathewsAugust 16, 2016Leave a comment

It’s a nail biting fight to the finish. In just three months, either Hillary Clinton or Donald Trump will be elected the next president of the United States.  At the moment, 43% of voters are in favor of Clinton.  Another 40% are likely to vote from Trump.  Libertarian Gary Johnson has about 8% favorability while…

Details
1
234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253
…5455565758…
5960616263646566676869707172737475767778798081828384858687888990919293
94
The Cheap Investor BBB Business Review

By signing up you will automatically opt in to receive free daily alerts from The Cheap Investor, as well as third party promotional offers. You can unsubscribe at any by selecting the unsubscribe at the bottom of our emails. Privacy Policy

DISCLAIMER: The Cheap Investor, together with its affiliates, is a publisher of financial news and opinions. Past performance is not a guarantee of future results. You alone are responsible for your own investment decisions. You should independently verify all information contained within newsletters, alerts and profiles or on our website(s) and consider obtaining professional advice before making any investment decision. Past performance is no guarantee of future success and you should not assume that the securities of companies profiled in current or future newsletters, alerts and profiles or on our website(s) will perform better than or even equal to the performance of the securities of companies profiled or mentioned in prior newsletters, alerts and profiles or on our website(s). All stock investments carry some degree of risk. By investing in any of the stocks of the companies profiled or mentioned in the newsletters, alerts and profiles or on our website(s) you can and may lose some or all of your investment. Do not invest in any stock if you are not prepared to lose your entire investment. As a condition to accessing The Cheap Investor materials and websites, you agree to our Full Disclaimer, Terms and Conditions of Use and Privacy Policy, including without limitation all disclaimers of warranties and limitations on liability contained therein. The Cheap Investor and its affiliates, principals, employees, partners, directors and agents may hold positions in the securities that are discussed in our newsletters or on our website. Please be sure to fully read all disclaimers and disclosures contained in newsletters, alerts and profiles or on our website(s).
Copyright 1981-2018 © Inspiren, LLC
Go to Top